InvestorsHub Logo
Followers 155
Posts 2683
Boards Moderated 0
Alias Born 01/29/2004

Re: None

Friday, 04/05/2019 9:19:25 PM

Friday, April 05, 2019 9:19:25 PM

Post# of 471589
Confirms My Perception

He [company official] said if we had the money, we'd be running a ton of trials.


Confirms my perception that Anavex insiders know full well the expansive applications of their molecules. Not just the three in clinical trials (Rett syndrome, Parkinson’s, and Alzheimer’s).

In five years, see if I’m correct, in believing the Anavex sigma-1 receptor agonists will be successful therapies for a large number of both Central Nervous System diseases and many others. Restoration and maintenance of various cellular homeostatic processes will be gigantic.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News